Your request has been received by DRG. A represantative will contact you shortly to provide more details on the research and data contained in this report and ensure that it will meet your current research needs.
A highly cost-conscious health care landscape in Europe has placed substantial downward pressure on the large yet contracting European IC device market. However, an expanding CAD patient pool, continued innovation, and increasing adoption of premium-priced devices—such as next-generation DES, BVS, DCBs, and intravascular imaging catheters and pressure guidewires—will mitigate overall revenue declines and fuel expansion in certain segments, including those for BVS and intravascular imaging catheters and pressure guidewires.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Europe across a 10-year period.
Continuing innovation in coronary stent technology will be a primary driver of the European IC device market
How will current-generation DES shape the European coronary stent market over the forecast period?
What is the outlook of the BVS segment following the withdrawal of Absorb?
Will BMS become obsolete during the forecast period?
What impact will recent events in the BVS space have on DES usage patterns?
How are DES technologies likely to evolve over the coming years?
Price competition will limit revenue growth potential, especially in light of increased cost-consciousness among health care facilities.
Which segments will experience the most price competition?
In which segments and to what extent will adoption of premium-priced next-generation products offset the effects of price competition?
What strategies may IC device manufacturers adopt to address the increasing cost-consciousness among health care facilities?
Emerging technologies such as FFRCT, resting-state FFR, and angiography-based FFR will influence the IC diagnostic landscape in Europe.
How will the adoption of FFRCT alter patient and procedure compositions in cardiac catheterization labs?
How will the emergence of alternative FFR modalities affect the FFR pressure guidewire market?
Already a Client? Log in to access this report.
Megha Maheshwari is a principal analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in interventional cardiology, aortic repair, and coronary artery bypass graft device markets. In addition to a postgraduate diploma in Hospital Administration with a Certificate in International Medical Tourism and an Associate's degree in Nutrition and Child Care, Megha holds a Bachelor's degree in Physiotherapy from Hemwati Nandan Bahuguna Garhwal University and an MBA in Healthcare IT from NIMS University.